Annual Current Liabilities
$7.42 M
+$6.83 M+1165.14%
30 April 2024
Summary:
PharmaCyte Biotech annual total current liabilities is currently $7.42 million, with the most recent change of +$6.83 million (+1165.14%) on 30 April 2024. During the last 3 years, it has risen by +$6.70 million (+923.91%). PMCB annual current liabilities is now at all-time high.PMCB Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$7.47 M
+$51.60 K+0.70%
31 July 2024
Summary:
PharmaCyte Biotech quarterly total current liabilities is currently $7.47 million, with the most recent change of +$51.60 thousand (+0.70%) on 31 July 2024. Over the past year, it has increased by +$2.23 million (+42.62%). PMCB quarterly current liabilities is now -0.87% below its all-time high of $7.54 million, reached on 31 January 2024.PMCB Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PMCB Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1165.1% | +42.6% |
| 3 y3 years | +923.9% | +3915.5% |
| 5 y5 years | +899.0% | +829.6% |
PMCB Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1165.1% | -0.9% | +3915.5% |
| 5 y | 5 years | at high | +1165.1% | -0.9% | +3915.5% |
| alltime | all time | at high | >+9999.0% | -0.9% | >+9999.0% |
PharmaCyte Biotech Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| July 2024 | - | $7.47 M(+0.7%) |
| Apr 2024 | $7.42 M(+1165.1%) | $7.42 M(-1.6%) |
| Jan 2024 | - | $7.54 M(+43.9%) |
| Oct 2023 | - | $5.24 M(+245.2%) |
| July 2023 | - | $1.52 M(+158.8%) |
| Apr 2023 | $586.60 K(-16.7%) | $586.60 K(-29.1%) |
| Jan 2023 | - | $827.80 K(-36.9%) |
| Oct 2022 | - | $1.31 M(+20.4%) |
| July 2022 | - | $1.09 M(+54.7%) |
| Apr 2022 | $704.40 K(-2.8%) | $704.40 K(+14.9%) |
| Jan 2022 | - | $613.00 K(+229.4%) |
| Oct 2021 | - | $186.10 K(-79.9%) |
| July 2021 | - | $925.00 K(+27.6%) |
| Apr 2021 | $724.80 K(-29.7%) | $724.80 K(+13.2%) |
| Jan 2021 | - | $640.30 K(-0.5%) |
| Oct 2020 | - | $643.70 K(-44.2%) |
| July 2020 | - | $1.15 M(+11.8%) |
| Apr 2020 | $1.03 M(+38.8%) | $1.03 M(+1.2%) |
| Jan 2020 | - | $1.02 M(+26.7%) |
| Oct 2019 | - | $803.90 K(+32.5%) |
| July 2019 | - | $606.60 K(-18.3%) |
| Apr 2019 | $742.90 K(+15.3%) | $742.90 K(+57.7%) |
| Jan 2019 | - | $471.20 K(-28.9%) |
| Oct 2018 | - | $662.40 K(-25.0%) |
| July 2018 | - | $882.90 K(+37.1%) |
| Apr 2018 | $644.20 K(+11.0%) | $644.20 K(-27.4%) |
| Jan 2018 | - | $887.20 K(+56.5%) |
| Oct 2017 | - | $567.00 K(-34.5%) |
| July 2017 | - | $865.70 K(+49.2%) |
| Apr 2017 | $580.20 K(-9.0%) | $580.20 K(+0.3%) |
| Jan 2017 | - | $578.30 K(+28.8%) |
| Oct 2016 | - | $449.00 K(-1.6%) |
| July 2016 | - | $456.50 K(-28.4%) |
| Apr 2016 | $637.60 K(-58.1%) | $637.60 K(-40.2%) |
| Jan 2016 | - | $1.07 M(-1.4%) |
| Oct 2015 | - | $1.08 M(-9.0%) |
| July 2015 | - | $1.19 M(-22.0%) |
| Apr 2015 | $1.52 M(+306.9%) | $1.52 M(+301.7%) |
| Jan 2015 | - | $378.50 K(+36.7%) |
| Oct 2014 | - | $276.90 K(-25.4%) |
| July 2014 | - | $371.40 K(-0.6%) |
| Apr 2014 | $373.70 K | $373.70 K(-22.0%) |
| Jan 2014 | - | $479.30 K(-51.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2013 | - | $991.00 K(-0.3%) |
| July 2013 | - | $994.20 K(-73.8%) |
| Apr 2013 | $3.80 M(+0.3%) | $3.80 M(+5.3%) |
| Jan 2013 | - | $3.61 M(+3.1%) |
| Oct 2012 | - | $3.50 M(-13.1%) |
| July 2012 | - | $4.03 M(+6.3%) |
| Apr 2012 | $3.79 M(+11.7%) | $3.79 M(+15.4%) |
| Jan 2012 | - | $3.28 M(-6.8%) |
| Oct 2011 | - | $3.52 M(+3.5%) |
| July 2011 | - | $3.40 M(+0.4%) |
| Apr 2011 | $3.39 M(+11.0%) | $3.39 M(-0.6%) |
| Jan 2011 | - | $3.41 M(+3.0%) |
| Oct 2010 | - | $3.31 M(+1.3%) |
| July 2010 | - | $3.27 M(+7.1%) |
| Apr 2010 | $3.05 M(+228.4%) | $3.05 M(+16.9%) |
| Jan 2010 | - | $2.61 M(+130.1%) |
| Oct 2009 | - | $1.14 M(+11.2%) |
| July 2009 | - | $1.02 M(+9.8%) |
| Apr 2009 | $929.90 K(+414.9%) | $929.90 K(+809.9%) |
| Jan 2009 | - | $102.20 K(+26.8%) |
| Oct 2008 | - | $80.60 K(+61.8%) |
| July 2008 | - | $49.80 K(-72.4%) |
| Apr 2008 | $180.60 K(+52.0%) | $180.60 K(+75.0%) |
| Jan 2008 | - | $103.20 K(-2.8%) |
| Oct 2007 | - | $106.20 K(+55.0%) |
| July 2007 | - | $68.50 K(-42.3%) |
| Apr 2007 | $118.80 K(+11.9%) | $118.80 K(-88.0%) |
| Jan 2007 | - | $991.60 K(+471.2%) |
| Oct 2006 | - | $173.60 K(+31.0%) |
| July 2006 | - | $132.50 K(+24.8%) |
| Apr 2006 | $106.20 K(-64.3%) | $106.20 K(-62.5%) |
| Jan 2006 | - | $283.50 K(+0.6%) |
| Oct 2005 | - | $281.80 K(+6.0%) |
| July 2005 | - | $265.80 K(-10.6%) |
| Apr 2005 | $297.40 K(>+9900.0%) | $297.40 K(+369.1%) |
| Jan 2005 | - | $63.40 K(+492.5%) |
| Oct 2004 | - | $10.70 K(+109.8%) |
| July 2004 | - | $5100.00(+1600.0%) |
| Apr 2004 | $300.00(-88.0%) | $300.00(-94.2%) |
| Jan 2004 | - | $5200.00(-7.1%) |
| Oct 2003 | - | $5600.00(+30.2%) |
| July 2003 | - | $4300.00(+72.0%) |
| Apr 2003 | $2500.00 | $2500.00 |
FAQ
- What is PharmaCyte Biotech annual total current liabilities?
- What is the all time high annual current liabilities for PharmaCyte Biotech?
- What is PharmaCyte Biotech annual current liabilities year-on-year change?
- What is PharmaCyte Biotech quarterly total current liabilities?
- What is the all time high quarterly current liabilities for PharmaCyte Biotech?
- What is PharmaCyte Biotech quarterly current liabilities year-on-year change?
What is PharmaCyte Biotech annual total current liabilities?
The current annual current liabilities of PMCB is $7.42 M
What is the all time high annual current liabilities for PharmaCyte Biotech?
PharmaCyte Biotech all-time high annual total current liabilities is $7.42 M
What is PharmaCyte Biotech annual current liabilities year-on-year change?
Over the past year, PMCB annual total current liabilities has changed by +$6.83 M (+1165.14%)
What is PharmaCyte Biotech quarterly total current liabilities?
The current quarterly current liabilities of PMCB is $7.47 M
What is the all time high quarterly current liabilities for PharmaCyte Biotech?
PharmaCyte Biotech all-time high quarterly total current liabilities is $7.54 M
What is PharmaCyte Biotech quarterly current liabilities year-on-year change?
Over the past year, PMCB quarterly total current liabilities has changed by +$2.23 M (+42.62%)